These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 12755659
1. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine. Russell JM, Kornstein SG, Shea MT, McCullough JP, Harrison WM, Hirschfeld RM, Keller MB. J Clin Psychiatry; 2003 May; 64(5):554-61. PubMed ID: 12755659 [Abstract] [Full Text] [Related]
2. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, Koran LM, Miller IW, Thase ME, Howland RH, Connolly MA, Miceli RJ. J Clin Psychiatry; 1998 Dec; 59(12):669-75. PubMed ID: 9921701 [Abstract] [Full Text] [Related]
3. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. Keller MB, Gelenberg AJ, Hirschfeld RM, Rush AJ, Thase ME, Kocsis JH, Markowitz JC, Fawcett JA, Koran LM, Klein DN, Russell JM, Kornstein SG, McCullough JP, Davis SM, Harrison WM. J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606 [Abstract] [Full Text] [Related]
5. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ, Markowitz JC, Schlager DS, Kornstein SG, Davis SM, Harrison WM, Keller MB. J Clin Psychiatry; 1998 Nov; 59(11):608-19. PubMed ID: 9862607 [Abstract] [Full Text] [Related]
7. The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. Rush AJ, Koran LM, Keller MB, Markowitz JC, Harrison WM, Miceli RJ, Fawcett JA, Gelenberg AJ, Hirschfeld RM, Klein DN, Kocsis JH, McCullough JP, Schatzberg AF, Thase ME. J Clin Psychiatry; 1998 Nov; 59(11):589-97. PubMed ID: 9862605 [Abstract] [Full Text] [Related]
8. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W. Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754 [Abstract] [Full Text] [Related]
15. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. Lydiard RB, Stahl SM, Hertzman M, Harrison WM. J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414 [Abstract] [Full Text] [Related]
16. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Baca E, Garcia-Garcia M, Porras-Chavarino A. Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858 [Abstract] [Full Text] [Related]
19. The relationship of personality disorders to treatment outcome in depressed outpatients. Mulder RT, Joyce PR, Luty SE. J Clin Psychiatry; 2003 Mar; 64(3):259-64. PubMed ID: 12716266 [Abstract] [Full Text] [Related]
20. Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial. Forlenza OV, Almeida OP, Stoppe A, Hirata ES, Ferreira RCR. Int Psychogeriatr; 2001 Mar; 13(1):75-84. PubMed ID: 11352337 [Abstract] [Full Text] [Related] Page: [Next] [New Search]